INO Stock Summary and Trading Ideas (Inovio Pharmaceuticals | NASDAQ:INO)

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.

As of December 17, 2025, INO stock price climbed to $2.60 with 4,481,079 million shares trading.

INO has a beta of 1.44, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.06 to the broad based SPY ETF.

INO has a market cap of $178.63 million. This is considered a Micro Cap stock.

Last quarter Inovio Pharmaceuticals reported $0 in Revenue and -$.44 earnings per share. This fell short of revenue expectation by $-8,330 and exceeded earnings estimates by $.05.

In the last 3 years, INO traded as high as $23.88 and as low as $1.30.

The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, IWC, MSSM.

INO has outperformed the market in the last year with a price return of +20.9% while the SPY ETF gained +11.8%. INO has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +14.0% and +35.4%, respectively, while the SPY returned +2.0% and -1.5%, respectively.

INO support price is $2.21 and resistance is $2.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO shares will trade within this expected range on the day.